En développement
Santé·22/04/2026Résumé IA
Millions Lose Insurance Coverage for GLP-1 Weight Loss Drugs as Patients Face Rising Costs
Research shows 12 million people lost coverage for Zepbound and 12 million for Wegovy from 2025 to 2026, with 88% of those who still have coverage facing restrictions. Patients like Meghan Lena, a Massachusetts teacher, describe losing coverage twice within months and being forced to pay $300 monthly for compounded alternatives or face treatment interruption.
N
NPR News4 min de lecture